Literature DB >> 3955505

Androgen receptor in human normal and malignant pancreatic tissue and cell lines.

T P Corbishley, M J Iqbal, M L Wilkinson, R Williams.   

Abstract

Estrogen and progestogen receptors have been demonstrated in human pancreatic adenocarcinoma tissue. Tumor growth as xenografts in nude mice is promoted by testosterone and retarded by cyproterone acetate but is not influenced by estrogens, progestogens, or their antagonists, although estrogen receptors were demonstrated in xenograft cytosol. A new sensitive microassay technique for sex steroid receptors which relies on affinity chromatography was used in this study. With this assay, androgen receptors were detected in five fresh human pancreatic adenocarcinoma specimens (three male), two pancreatic cancer cell lines (Mia PaCa 2 and Ger), one xenograft tumor which responded to androgens, five specimens of normal adult pancreas (two male), and a pool of fetal pancreatic tissue. The similarity of the androgen receptor in pancreatic carcinoma to that of classical androgen target organs was demonstrated by sedimentation behavior and competitive binding studies. The improved sensitivity of the microassay allowed low levels of estrogen, androgen, and progesterone receptors to be detected in normal adult pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955505     DOI: 10.1002/1097-0142(19860515)57:10<1992::aid-cncr2820571019>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Characteristics of pancreatic carcinoma in the elderly.

Authors:  T Kamisawa; T Yuyang; N Egawa; J Ishiwata; K Tsuruta; A Okamoto; M Koike
Journal:  Int J Pancreatol       Date:  1998-08

Review 2.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

4.  Cytosolic estrogen and progesterone receptors in exocrine pancreatic adenocarcinoma.

Authors:  C Mao; D Desaty; J M Howard
Journal:  Int J Pancreatol       Date:  1994-04

5.  Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas.

Authors:  C Doglioni; M Gambacorta; G Zamboni; G Coggi; G Viale
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

Review 6.  Influence of sex hormones on pancreatic cancer.

Authors:  A Andrén-Sandberg; J Johansson
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

7.  Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer.

Authors:  J J Sharma; B Razvillas; C D Stephens; S G Hilsenbeck; A Sharma; M L Rothenberg
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 8.  Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.

Authors:  D Perilli; C Mansi; V Savarino; G Celle
Journal:  Int J Pancreatol       Date:  1993-06

9.  Detection of androgen receptors in human esophageal cancer.

Authors:  Y Yamashita; T Hirai; H Mukaida; K Kawano; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1989-03

Review 10.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.